
Bayer bags first world approval for hot flush therapy
Bayer has its first regulatory approval for non-hormonal menopause treatment elinzanetant – in the UK – as it chases down a rival drug from Astellas.
Newsletters and Deep Dive digital magazine
Bayer has its first regulatory approval for non-hormonal menopause treatment elinzanetant – in the UK – as it chases down a rival drug from Astellas.
The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
EU President Ursula von der Leyen has survived a no-confidence vote over text messages she sent to Pfizer's CEO about COVID-19 vaccine procurement.
Eli Lilly's Omvoh has been recommended for use in Crohn's disease by NICE, while BeOne's Brukinsa gets the go-ahead for mantle cell lymphoma.
NICE’s modular update on health inequalities, consulted on in January and finalised in May, has now been incorporated into its manual.1 A total of 26 individuals and organi
Editor's Picks
Newsletters and Deep Dive
digital magazine